Abstract
Aims and Objectives
To evaluate technical feasibility, long-term primary patency and clinical outcome of the transjugular intrahepatic portosystemic shunt (TIPS) through the struts of the previously placed stents.
Materials and Methods
Retrospective evaluation of seven consecutive patients (three male and four female, age range 13–65 years, median 28) out of a total 95 patients, who underwent TIPS through the strut of the previously placed stents of hepatic vein (HV), inferior vena cava (IVC) or TIPS in a single tertiary care hospital. Six of the patients were diagnosed with Budd–Chiari syndrome (BCS) and one with alcohol-induced chronic liver disease (CLD). Kaplan–Meier test was used to calculate 18- and 60-month primary patency rate of TIPS stent.
Results
TIPS through the strut of a previously placed stent was technically successful in all the patients (100%). The TIPS was direct intrahepatic portosystemic shunt (DIPS) in 5/7 cases, due to occluded HV. Mean portosystemic pressure gradient (PPG) reduced from 24 mmHg ± 5.9 (range, pre-TIPS 15–31 mmHg) to 8.57 mmHg ± 4.4 (range, post-TIPS, 3–14 mmHg). One patient required three sessions of TIPS revisions. Another patient needed TIPS revision after 5 years of TIPS creation. All the patients showed improvement in clinical symptoms and in mean Child–Turcotte–Pugh (CTP) score and modified end-stage liver disease (MELD) score during mean follow-up period 40.57 month ± 34.9 (range 3–100 month). Primary patency rates of TIPS stent measured with Kaplan–Meier estimate at 18- and 60-month follow-up were 80% (95% CI, 37–97%) and 40% (95% CI, 10–97%), respectively.
Conclusion
TIPS through the strut of a previously placed stent is technically feasible with good long-term primary patency and clinical outcome.
References
Mancuso A. An update on management of Budd–Chiari syndrome. Ann Hepatol. 2014;13(3):323–6.
Surendrababu NR, Keshava SN, Eapen CE, Zachariah UG. Transjugular intrahepatic portocaval shunt placed through the strut of an inferior vena cava stent in a patient with Budd–Chiari syndrome: a technical modification. Br J Radiol. 2010;83(985):e22–4.
Keshava SN, Kota GK, Mammen T, Jeyamani R, Moses V, Govil S, Kurian G, Chandy G. Direct intrahepatic cavo-portal shunts in Budd–Chiari syndrome: role of simultaneous fluoroscopy and trans-abdominal ultrasonography. Indian J Gastroenterol. 2006;25(5):248–50.
Lefèvre T, Louvard Y, Morice MC, Loubeyre C, Piéchaud JF, Dumas P. Stenting of bifurcation lesions: a rational approach. J Interv Cardiol. 2001;14(6):573–85.
Joseph R, Keshava SN, Narayanam RS, John GT. Placement of a catheter through the struts of a previously placed stent for maintenance hemodialysis: a case report. Semin Dial. 2008;21(6):575–7.
Tsauo J, Yu Y, Luo X, Wang Z, Liu L, Li X. Direct intrahepatic portocaval shunt creation via the inter-strut space of the inferior vena cava stent. Clin Radiol. 2014;69(9):896–9.
Livingstone RS, Keshava SN. Technical note: reduction of radiation dose using ultrasound guidance during transjugular intrahepatic portosystemic shunt procedure. Indian J Radiol Imaging. 2011;21(1):13–4.
He FL, Wang L, Yue ZD, Zhao HW, Liu FQ. Parallel transjugular intrahepatic portosystemic shunt for controlling portal hypertension complications in cirrhotic patients. World J Gastroenterol. 2014;20(33):11835–9.
Gandini R, Konda D, Simonetti G. Transjugular intrahepatic portosystemic shunt patency and clinical outcome in patients with Budd–Chiari syndrome: covered versus uncovered stents. Radiology. 2006;241(1):298–305.
Hernández-Guerra M, Turnes J, Rubinstein P, Olliff S, Elias E, Bosch J, et al. PTFE-covered stents improve TIPS patency in Budd–Chiari syndrome. Hepatology. 2004;40(5):1197–202.
Weber CN, Nadolski GJ, White SB, Clark TW, Mondschein JI, Stavropoulos SW, et al. Long-term patency and clinical analysis of expanded polytetrafluoroethylene—covered transjugular intrahepatic portosystemic shunt stent grafts. J Vasc Interv Radiol. 2015;26(9):1257–65.
Geeroms B, Laleman W, Laenen A, Heye S, Verslype C, van der Merwe S, et al. Expanded polytetrafluoroethylene-covered stent-grafts for transjugular intrahepatic portosystemic shunts in cirrhotic patients: Long term patency and clinical outcome results. Euro Radiol. 2017;27(5):1795–803.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical Approval
This is a retrospective study. For this type of study formal consent is not required.
Rights and permissions
About this article
Cite this article
Ahmed, M., Keshava, S.N., Moses, V. et al. Transjugular Intrahepatic Portosystemic Shunt Through the Strut of a Previously Placed Stent: Technical Feasibility and Long-Term Follow-Up Results. Cardiovasc Intervent Radiol 41, 1794–1798 (2018). https://doi.org/10.1007/s00270-018-2033-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-018-2033-x